368 related articles for article (PubMed ID: 25719457)
1. The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature.
Meuwissen ME; Halley DJ; Smit LS; Lequin MH; Cobben JM; de Coo R; van Harssel J; Sallevelt S; Woldringh G; van der Knaap MS; de Vries LS; Mancini GM
Genet Med; 2015 Nov; 17(11):843-53. PubMed ID: 25719457
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of COL4A1 and COL4A2 mutations in severe fetal multifocal hemorrhagic and/or ischemic cerebral lesions.
Maurice P; Guilbaud L; Garel J; Mine M; Dugas A; Friszer S; Maisonneuve E; Moutard ML; Coste T; Héron D; Tournier-Lasserve E; Garel C; Jouannic JM
Ultrasound Obstet Gynecol; 2021 May; 57(5):783-789. PubMed ID: 32515830
[TBL] [Abstract][Full Text] [Related]
3. A mutation in COL4A2 causes autosomal dominant porencephaly with cataracts.
Ha TT; Sadleir LG; Mandelstam SA; Paterson SJ; Scheffer IE; Gecz J; Corbett MA
Am J Med Genet A; 2016 Apr; 170A(4):1059-63. PubMed ID: 26708157
[TBL] [Abstract][Full Text] [Related]
4. COL4A2 mutation associated with familial porencephaly and small-vessel disease.
Verbeek E; Meuwissen ME; Verheijen FW; Govaert PP; Licht DJ; Kuo DS; Poulton CJ; Schot R; Lequin MH; Dudink J; Halley DJ; de Coo RI; den Hollander JC; Oegema R; Gould DB; Mancini GM
Eur J Hum Genet; 2012 Aug; 20(8):844-51. PubMed ID: 22333902
[TBL] [Abstract][Full Text] [Related]
5. Leukoencephalopathy with spot-like calcifications caused by recessive COL4A2 variants.
Nicita F; Aiello C; Carboni A; Longo D; Bertini E; Travaglini L
Clin Neurol Neurosurg; 2023 Feb; 225():107584. PubMed ID: 36603335
[TBL] [Abstract][Full Text] [Related]
6. COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy.
Gunda B; Mine M; Kovács T; Hornyák C; Bereczki D; Várallyay G; Rudas G; Audrezet MP; Tournier-Lasserve E
J Neurol; 2014 Mar; 261(3):500-3. PubMed ID: 24390199
[TBL] [Abstract][Full Text] [Related]
7. Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations.
Kuo DS; Labelle-Dumais C; Mao M; Jeanne M; Kauffman WB; Allen J; Favor J; Gould DB
Hum Mol Genet; 2014 Apr; 23(7):1709-22. PubMed ID: 24203695
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
Jeanne M; Jorgensen J; Gould DB
Circulation; 2015 May; 131(18):1555-65. PubMed ID: 25753534
[TBL] [Abstract][Full Text] [Related]
9. Infantile hemiparesis and porencephaly due to a COL4A1 mutation: Gould syndrome.
Burns A; Hug J
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38355202
[TBL] [Abstract][Full Text] [Related]
10. Further refinement of COL4A1 and COL4A2 related cortical malformations.
Cavallin M; Mine M; Philbert M; Boddaert N; Lepage JM; Coste T; Lopez-Gonzalez V; Sanchez-Soler MJ; Ballesta-Martínez MJ; Remerand G; Pasquier L; Guët A; Chelly J; Lascelles K; Prieto-Morin C; Kossorotoff M; Tournier Lasserve E; Bahi-Buisson N
Eur J Med Genet; 2018 Dec; 61(12):765-772. PubMed ID: 30315939
[TBL] [Abstract][Full Text] [Related]
11. COL4A1 mutations in two infants with congenital cataracts and porencephaly: an ophthalmologic perspective.
Nau S; McCourt EA; Maloney JA; Van Hove JL; Saenz M; Jung JL
J AAPOS; 2019 Aug; 23(4):246-248. PubMed ID: 31128271
[TBL] [Abstract][Full Text] [Related]
12. COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.
Labelle-Dumais C; Schuitema V; Hayashi G; Hoff K; Gong W; Dao DQ; Ullian EM; Oishi P; Margeta M; Gould DB
Am J Hum Genet; 2019 May; 104(5):847-860. PubMed ID: 31051113
[TBL] [Abstract][Full Text] [Related]
13. Do mutations in COL4A1 or COL4A2 cause thin basement membrane nephropathy (TBMN)?
Zhang KW; Tonna S; Wang YY; Rana K; Padavarat S; Savige J
Pediatr Nephrol; 2007 May; 22(5):645-51. PubMed ID: 17216253
[TBL] [Abstract][Full Text] [Related]
14. Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles.
Favor J; Gloeckner CJ; Janik D; Klempt M; Neuhäuser-Klaus A; Pretsch W; Schmahl W; Quintanilla-Fend L
Genetics; 2007 Feb; 175(2):725-36. PubMed ID: 17179069
[TBL] [Abstract][Full Text] [Related]
15. Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.
Murray LS; Lu Y; Taggart A; Van Regemorter N; Vilain C; Abramowicz M; Kadler KE; Van Agtmael T
Hum Mol Genet; 2014 Jan; 23(2):283-92. PubMed ID: 24001601
[TBL] [Abstract][Full Text] [Related]
16. Two families with novel missense mutations in COL4A1: When diagnosis can be missed.
Giorgio E; Vaula G; Bosco G; Giacone S; Mancini C; Calcia A; Cavalieri S; Di Gregorio E; Rigault De Longrais R; Leombruni S; Pinessi L; Cerrato P; Brusco A; Brussino A
J Neurol Sci; 2015 May; 352(1-2):99-104. PubMed ID: 25873210
[TBL] [Abstract][Full Text] [Related]
17. Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus.
Karolak JA; Kulinska K; Nowak DM; Pitarque JA; Molinari A; Rydzanicz M; Bejjani BA; Gajecka M
Mol Vis; 2011 Mar; 17():827-43. PubMed ID: 21527998
[TBL] [Abstract][Full Text] [Related]
18. De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly.
Yoneda Y; Haginoya K; Arai H; Yamaoka S; Tsurusaki Y; Doi H; Miyake N; Yokochi K; Osaka H; Kato M; Matsumoto N; Saitsu H
Am J Hum Genet; 2012 Jan; 90(1):86-90. PubMed ID: 22209246
[TBL] [Abstract][Full Text] [Related]
19. Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome.
Mao M; Popli T; Jeanne M; Hoff K; Sen S; Gould DB
Dis Model Mech; 2021 Apr; 14(4):. PubMed ID: 34424299
[TBL] [Abstract][Full Text] [Related]
20. Biallelic COLGALT1 variants are associated with cerebral small vessel disease.
Miyatake S; Schneeberger S; Koyama N; Yokochi K; Ohmura K; Shiina M; Mori H; Koshimizu E; Imagawa E; Uchiyama Y; Mitsuhashi S; Frith MC; Fujita A; Satoh M; Taguri M; Tomono Y; Takahashi K; Doi H; Takeuchi H; Nakashima M; Mizuguchi T; Takata A; Miyake N; Saitsu H; Tanaka F; Ogata K; Hennet T; Matsumoto N
Ann Neurol; 2018 Dec; 84(6):843-853. PubMed ID: 30412317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
